Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 6, 2025
A review of physiologically based pharmacokinetic modeling of renal drug dispositionWeize Huang, Christine Bowman, Mengyue Yin, et al.
Cannabis and Cannabinoid Research|November 18, 2021
Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological OutcomesWeize Huang, Lindsay C Czuba, Jennifer A Manuzak, et al.
British Journal of Clinical Pharmacology|October 19, 2023
Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysisBehnam Noorani, Rajeev M Menon, Xin Chen, et al.
British Journal of Clinical Pharmacology|October 21, 2023
Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acneYuqian Zhao, Jay C Vary, Aprajita S Yadav, et al.
The Journal of Biological Chemistry|June 7, 2019
The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearanceGuo Zhong, Cathryn Hogarth, Jessica M Snyder, et al.
Clinical and Translational Science|December 31, 2020
Altered vitamin A metabolism in human liver slices corresponds to fibrogenesisLindsay C Czuba, Xia Wu, Weize Huang, et al.
Clinical Pharmacology and Therapeutics|December 10, 2021
Clinical Pharmacology Perspectives for Adoptive Cell Therapies in OncologyWeize Huang, Junyi Li, Michael Z Liao, et al.
Hematological Oncology|September 23, 2023
Venetoclax in biomarker-selected multiple myeloma patients: Impact of exposure on clinical efficacy and safetyMohamed Badawi, Sheryl Coppola, Doerthe Eckert, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2020
Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in miceJessica M Snyder, Guo Zhong, Cathryn Hogarth, et al.
Pageof 3